SINGAPORE (Apr 24): RHB is initiating coverage on UG Healthcare with a “buy” recommendation and a target price of 32 cents, as the research house is positive on the long term global demand growth for gloves, with demand rising at a 5.7% CAGR over the past 12 years.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply